Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-25

Clinical Trial Update: Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated mirtazapine for cocaine use disorder in individuals with co-occurring depression; the study was completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remeron (mirtazapine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Dependence, Depression | Phase 2 | Status: COMPLETED | Results posted: 2017-10-25